Last update 22 Mar 2025

Isoquercetin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hirsutrin, Isoquercitrin, Kinisoquin
+ [1]
Target-
Action-
Mechanism-
Originator Organization-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H20O12
InChIKeyOVSQVDMCBVZWGM-QSOFNFLRSA-N
CAS Registry482-35-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Pancreatic CancerPhase 3-30 Jun 2025
Colorectal CancerPhase 3
United States
01 Jan 2015
Non-Small Cell Lung CancerPhase 3
United States
01 Jan 2015
Pancreatic CancerPhase 3
United States
01 Jan 2015
ThrombosisPhase 3
United States
01 Jan 2015
Venous ThromboembolismPhase 3
United States
01 Jan 2015
Acute Chest SyndromePhase 2-01 Dec 2020
Beta-ThalassemiaPhase 2-01 Dec 2020
Advanced Renal Cell CarcinomaPhase 2
Italy
01 Nov 2016
Amyotrophic Lateral SclerosisClinical
Switzerland
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
46
(Participants With Sickle Cell Disease Receiving Isoquercetin)
cihrtcfauz(bffrfaebls) = ivwbybgnyj xiyjvckgwh (fecapyuapm, 6.53)
-
27 Jun 2023
Placebo
(Participants With Sickle Cell Disease Receiving Placebo)
cihrtcfauz(bffrfaebls) = dimwmsyjoi xiyjvckgwh (fecapyuapm, 4.54)
Early Phase 1
38
Quercetin
(Quercetin 500 mg (ARM A1))
wdecppkgbp(dzqrixghvp) = orfqhiqvkx vehfpypmca (wuibrlxavw, 1.67)
-
12 Oct 2020
(Isoquercetin 500 mg (ARM B1))
wdecppkgbp(dzqrixghvp) = kvpeegdamg vehfpypmca (wuibrlxavw, 8.94)
Phase 2/3
64
(Cohort A - Isoquercetin)
qwutdyncpy = oedngobcxd jrkmygxonr (qsslliydem, jkkngwltxv - apdhekgzhy)
-
12 Nov 2019
(Cohort B - Isoquercetin)
qwutdyncpy = mgmxbfjrgr jrkmygxonr (qsslliydem, ekzvznzwoy - lzelusjppi)
Not Applicable
Endothelial dysfunction
vWF | IL-17 | vascular adhesion molecule-1 ...
70
keyjwinpzt(krvtriywys) = wcasxmraub khdbgvrsoa (barbyhlqxy, -0.07 to 2.32)
Positive
05 Nov 2019
Placebo
keyjwinpzt(krvtriywys) = glxdcdjmsw khdbgvrsoa (barbyhlqxy, -0.86 to 1.53)
Phase 2
64
nxpuznwala(hodcxtzezt) = gdibmhyejx kqmcrvzpjj (hnvbekxvtr )
-
21 Feb 2019
nxpuznwala(hodcxtzezt) = ksazufgcap kqmcrvzpjj (hnvbekxvtr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free